Welcome to our dedicated page for Harte Hanks news (Ticker: HHS), a resource for investors and traders seeking the latest updates and insights on Harte Hanks stock.
About Harte Hanks (NASDAQ: HHS)
Harte Hanks is a globally recognized customer experience (CX) company with over a century of expertise in helping businesses connect more effectively with their customers. Headquartered in Chelmsford, Massachusetts, Harte Hanks offers a robust portfolio of solutions across Marketing Services, Customer Care, and Fulfillment & Logistics Services. These services are designed to provide end-to-end support for businesses, from data-driven analytics and actionable insights to seamless execution of marketing campaigns and customer interaction strategies.
Core Business Segments
- Marketing Services: Harte Hanks specializes in creating data-driven marketing strategies that help businesses attract and engage their target audiences. This includes campaign management, content creation, and digital marketing solutions tailored to various industries.
- Customer Care: The company offers comprehensive customer support solutions, including call center operations, AI-assisted agent training, and personalized customer interactions. These services aim to enhance customer satisfaction and loyalty.
- Fulfillment & Logistics Services: Harte Hanks provides efficient logistics and fulfillment services, including inventory management, order processing, and distribution. This segment supports businesses in delivering timely and accurate services to their customers.
Market Presence and Competitive Position
With a strong geographic presence in the United States and operations across Europe and Asia Pacific, Harte Hanks serves a diverse range of industries, including healthcare, consumer goods, automotive, and technology. The company has a proven track record of delivering measurable results for globally recognized brands such as GlaxoSmithKline, Unilever, Pfizer, Volvo, and IBM. Its ability to integrate advanced technologies like AI and data analytics into its services sets it apart in the competitive CX landscape.
Strategic Initiatives and Innovation
Harte Hanks continuously evolves its offerings to meet the changing needs of its clients. Recent initiatives include the launch of AI-powered solutions like "Demand Generation In a Box," designed to streamline lead generation and sales for small and medium businesses. The company also collaborates with innovative platforms like Reddy to enhance agent training and customer care operations. These efforts demonstrate Harte Hanks' commitment to leveraging technology for improved customer outcomes.
Key Differentiators
- Data-Driven Insights: Harte Hanks excels in utilizing analytics to derive actionable insights, enabling businesses to make informed decisions.
- Comprehensive Service Offering: Its end-to-end solutions cover the entire customer lifecycle, from initial engagement to post-sale support.
- Industry Expertise: With over 100 years of experience, Harte Hanks brings unparalleled expertise and a deep understanding of customer behavior and market dynamics.
- Global Reach: The company’s international footprint allows it to serve a wide range of clients across various markets and industries.
Commitment to Excellence
Harte Hanks is dedicated to delivering exceptional value to its clients through innovative solutions and a customer-first approach. By combining its expertise in CX strategy, data analytics, and program execution, the company empowers businesses to build stronger, lasting relationships with their customers.
For more information, visit Harte Hanks’ official website.
On May 18, 2022, Harte Hanks (NASDAQ: HHS) announced its participation in The LD Micro Invitational XII on June 7-8, 2022, held at the Four Seasons in Los Angeles. CEO Brian Linscott and CFO Lauri Kearnes will present on June 7 at 4 p.m. PT, with a live stream available online. They will also hold one-on-one meetings for investors on both days. Interested attendees can email hhs@fnkir.com to schedule meetings. Harte Hanks continues to enhance its customer experience strategies across various industries.
Harte Hanks (HHS) reported a 12% increase in Q1 revenues, reaching $49.0 million compared to $43.8 million in Q1 2021. The company achieved a net income of $3.3 million, reversing a net loss of $1.8 million from the prior year. Operating income improved to $3.9 million, up from an operating loss of $0.9 million. Growth was seen across all segments, particularly in Fulfillment & Logistics services, which saw a 28% increase. The company anticipates a $7.6 million NOL tax refund in 2022, supporting their liquidity.
Harte Hanks (Nasdaq: HHS) will release its financial results for Q1 2022 on May 12, 2022, following market close. A conference call is scheduled for the same day at 4:30 p.m. ET to discuss the results. The event will be accessible via webcast and telephone for interested parties. The company specializes in customer experience solutions, providing analytics and insights to help clients engage better with customers. Harte Hanks has a solid client base, including major brands such as Ford and Pfizer.
Harte Hanks (Nasdaq: HHS) has secured a contract with a multinational technology firm to enhance its B2B marketing through an omnichannel program. This agreement will leverage Harte Hanks' extensive experience in managing partner reseller initiatives, program strategy, media buying, and data analytics. CEO Brian Linscott emphasizes the focus on investing in technology and talent to foster growth for clients while optimizing their resources. The company boasts a long-term track record in delivering customer experience solutions across global markets.
Harte Hanks (Nasdaq: HHS) has announced its participation in the Noble Capital Markets' 18th Annual Investor Conference (NobleCon18) scheduled for April 20, 2022. The presentation will occur at 9:30 a.m. ET, at the Hard Rock Hotel & Casino in Hollywood, Florida. CEO Brian Linscott and CFO Lauri Kearnes will lead the discussion, with breakout sessions at 1:45 p.m. ET and 3:15 p.m. ET. Interested participants can register via Noble Capital Markets' website. A video webcast will be available the following day on Harte Hanks' investor relations site.
Harte Hanks (Nasdaq: HHS) partnered with a leading global financial services corporation to deliver over 300,000 at-home Covid-19 testing kits during the Omicron surge. Additionally, the company distributed more than 60,000 wellness kits containing hand sanitizers and PPE masks to its employees. This initiative was supported by their FDA-certified distribution center in Kansas City, allowing prompt delivery. The company emphasizes its significant investments in fulfillment facilities as a driver of growth amidst ongoing supply chain challenges.
Harte Hanks (HHS) reported a 10% revenue increase in Q4 2021, totaling $52.0 million, up from $47.1 million in Q4 2020. Diluted EPS rose to $0.20 from $0.11. Full-year revenues also improved by 10% to $194.6 million, while net income surged to $15.0 million compared to a net loss of $1.7 million in 2020. The company achieved an operating income of $7.6 million, reversing a previous loss. Cash and equivalents decreased to $15.1 million, but the company expects a $7.8 million tax refund to boost liquidity. CEO Brian Linscott emphasized sustainable profitability growth in 2022.
Harte Hanks, Inc. (Nasdaq: HHS) announced it will release its financial results for Q4 ended December 31, 2021, after the market closes on February 24, 2022. A conference call will follow at 4:30 p.m. ET to discuss the results. Interested parties can access the webcast online or via phone. The company specializes in customer experience strategies and analytics, serving clients like Bank of America and Pfizer, with over 2,500 employees in multiple regions.
Harte Hanks (Nasdaq: HHS) has secured a multi-year contract from a national healthcare organization to provide new mothers with essential products, including breast milk pumps and health-related materials. This initiative aligns with the Affordable Care Act's goal to enhance newborn nutrition. Over 100,000 breast milk kits are expected to be delivered in the first year. Harte Hanks was chosen for its comprehensive, cost-effective solutions and established relationship with the client, enabling efficient service delivery.
Harte Hanks (Nasdaq: HHS) announced the launch of an expanded healthcare practice, spearheaded by Janel Harris, an executive with extensive healthcare agency experience. The practice aims to leverage integrated services including patient insights and data analytics, enhancing client engagement in the healthcare sector. The company operates multiple distribution centers, including a new 400,000 square foot facility in Kansas City, fulfilling over 1.3 million packages annually. Harte Hanks continues to cater to major clients like GSK and Pfizer, aiming to provide comprehensive patient-centric solutions.
FAQ
What is the current stock price of Harte Hanks (HHS)?
What is the market cap of Harte Hanks (HHS)?
What does Harte Hanks do?
What industries does Harte Hanks serve?
How does Harte Hanks differentiate itself from competitors?
What is Harte Hanks' geographic presence?
What innovative solutions does Harte Hanks offer?
What are Harte Hanks' core business segments?
Who are some of Harte Hanks' major clients?
How does Harte Hanks use AI in its services?
